# Astellas Pharma (China)

> organization

**Wikidata**: [Q100955910](https://www.wikidata.org/wiki/Q100955910)  
**Source**: https://4ort.xyz/entity/astellas-pharma-china

## Summary
Astellas Pharma (China) is a business organization operating as a subsidiary of Astellas Pharma, headquartered in Beijing, China. Founded in 2005, it functions as the Chinese arm of the global pharmaceutical company within the People's Republic of China.

## Key Facts
- **Entity Type:** Business (organization undertaking commercial, industrial, or professional activity)
- **Founded:** 2005
- **Parent Organization:** Astellas Pharma
- **Headquarters Location:** Beijing, People's Republic of China
- **Coordinates:** 39.893447°N, 116.473557°E
- **Official Website:** https://www.astellas.com.cn/
- **Country:** People's Republic of China
- **ISNI:** 0000000417582342
- **ROR ID:** 008h8bh21
- **GRID ID:** grid.508565.b
- **Ringgold ID:** 159794 (registered as "Astellas Pharma China Inc")
- **SciLit Organization ID:** 98169
- **Alias:** Asuterasu Seiyaku Kabushiki-gaisha

## FAQs
**What is Astellas Pharma (China)?**
Astellas Pharma (China) is a Chinese business entity that operates as a subsidiary of Astellas Pharma. Established in 2005, it is a pharmaceutical organization headquartered in Beijing.

**Where is Astellas Pharma (China) located?**
The company's headquarters is located in Beijing, the capital of the People's Republic of China. The specific geographic coordinates of its headquarters are 39.893447°N, 116.473557°E.

**Who owns or controls Astellas Pharma (China)?**
Astellas Pharma (China) is a part of Astellas Pharma, meaning it operates as a subsidiary of the larger global pharmaceutical corporation.

**How is Astellas Pharma (China) identified in academic and research databases?**
The organization is indexed in multiple identification systems including ISNI (0000000417582342), ROR ID (008h8bh21), GRID ID (grid.508565.b), Ringgold ID (159794), and SciLit Organization ID (98169).

## Why It Matters
Astellas Pharma (China) represents the localized presence of a global pharmaceutical corporation within the world's second-largest economy and most populous nation. Operating from Beijing—the political, cultural, and economic center of China—the subsidiary is positioned to serve a market of over 1.44 billion people. Its establishment in 2005 reflects the strategic importance of the Chinese healthcare and pharmaceutical sector to multinational companies. By maintaining operations in Beijing, a global city with a nominal GDP of 3.61 trillion renminbi, Astellas Pharma (China) benefits from proximity to government regulatory bodies, major research institutions, and a large urban population of over 21 million people in the capital alone.

## Notable For
- **Strategic Capital Location:** Being headquartered in Beijing, China's capital and a global city with over 21 million residents.
- **Subsidiary of a Global Pharma Corporation:** Operating as a direct part of Astellas Pharma, linking Chinese operations to an international pharmaceutical network.
- **Market Position in China:** Providing a corporate foothold in the People's Republic of China, the world's most populous country and second-largest economy by nominal GDP.
- **Multi-System Academic Indexing:** Being tracked across numerous global research identification databases including ROR, GRID, ISNI, Ringgold, and SciLit.

## Body

### Corporate Structure and Ownership
Astellas Pharma (China) is classified as a business entity, defined as an organization undertaking commercial, industrial, or professional activities. It operates as a part of Astellas Pharma, its parent organization. As a juridical person and economic entity, it functions within the legal and regulatory framework of the People's Republic of China. The company is also known by the alias "Asuterasu Seiyaku Kabushiki-gaisha," reflecting the Japanese origins of its parent company. The Ringgold database records it under the name "Astellas Pharma China Inc."

### Location and Geography
The company's headquarters is situated in Beijing, the capital city of the People's Republic of China. Beijing has served as the country's capital since October 1, 1949, when the People's Republic was founded. The city is a direct-administered municipality located in North China, covering an area of 16,410.54 square kilometers with an average elevation of 43 meters above sea level. Beijing is divided into 16 districts, including Dongcheng, Xicheng, Chaoyang, and Haidian. The specific coordinates of Astellas Pharma (China)'s headquarters are 39.893447°N, 116.473557°E. As of the 2020 census, Beijing's permanent population was 21,893,095, with 10,697,705 males and 11,195,390 females.

### History and Establishment
Astellas Pharma (China) was established in 2005. This founding occurred during a period of continued economic growth in China, following the country's accession to the World Trade Organization in 2001. The company has operated in the Chinese pharmaceutical market for nearly two decades.

### Operational Context in the People's Republic of China
The subsidiary operates within the People's Republic of China, a sovereign socialist state in East Asia. China has a population of approximately 1.44 billion people (2021 estimate) and the world's second-largest economy by nominal GDP, valued at approximately $17.96 trillion in 2022. The country operates as a one-party state under the leadership of the Chinese Communist Party, with Xi Jinping serving as President since March 2013 and Li Qiang as Premier since March 2023. The official language is Standard Chinese (Putonghua), and the currency is the Renminbi (yuan). China's literacy rate is 96.8%, and life expectancy is approximately 79 years.

### Digital Presence and Identification
Astellas Pharma (China) maintains an official website at https://www.astellas.com.cn/. The organization is tracked in multiple global research and academic identification systems:
- **ISNI (International Standard Name Identifier):** 0000000417582342
- **ROR (Research Organization Registry):** 008h8bh21
- **GRID (Global Research Identifier Database):** grid.508565.b
- **Ringgold ID:** 159794
- **SciLit Organization ID:** 98169

These identifiers facilitate the tracking and identification of the organization across academic publishing, research collaboration, and institutional databases worldwide.

### Beijing as an Operational Hub
Beijing serves as a major hub for multinational corporations, financial institutions, and technology companies. The city's nominal GDP was 3.61 trillion renminbi in 2020. It operates on UTC+08:00 (China Standard Time) and is home to numerous universities and research institutions, including Peking University and Tsinghua University. The city is served by major transportation infrastructure, including Beijing Capital International Airport and Beijing Daxing International Airport, which opened in 2019. Beijing has hosted major international events including the 2008 Summer Olympics and the 2022 Winter Olympics.

### Business and Regulatory Environment
As a business entity operating in China, Astellas Pharma (China) functions within a mixed economy that has transitioned from a centrally planned system since economic reforms began in 1978. China's service sector accounts for over 50% of GDP, and the country is the world's largest manufacturing nation, producing approximately 30% of global manufacturing output. The VAT rate in China is 13%. The country maintains a Gini coefficient of 38.2 (2019) and a Human Development Index of 0.768 (2021), classified as "High." Emergency services are accessible via 110 (police), 119 (fire), and 120 (ambulance), and the international calling code is +86.

## References

1. GRID release 2020-10-06
2. Aligned ISNI and Ringgold identifiers for institutions
3. ROR Data Dump 6.0 (October 2020)